Micro Labs Limited Irbesartan Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Irbesartan Export Records India — #12 Exporter, 41 Shipments, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Irbesartan

India Pharmaceutical Trade Intelligence

$106.3M123 Suppliers68 CountriesHS 30049079

ExportsIndia → UNITED STATES37.2%India → FRANCE15.4%

ImportsSPAIN → India$149.9K UNITED STATES → India$19.2K

#1 Buyer: MACLEODS PHARMA

Micro Labs Limited — Irbesartan Exporter #12 | $1.3M Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Irbesartan Exporter Profile

Indian Pharmaceutical Exporter · #12 for Irbesartan · $1.3M export value · DGFT Verified

Micro Labs Limited is the #12 Indian exporter of Irbesartan with $1.3M in export value and 41 verified shipments. Micro Labs Limited holds a 1.2% market share in Irbesartan exports across 6 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Irbesartan Export Profile: Buyers & Destinations

Micro Labs Limited Irbesartan export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Irbesartan?

Country	Value	Shipments	Share
AUSTRALIA	$564.7K	22	48.6%
UNITED KINGDOM	$430.8K	12	37.1%
GERMANY	$115.3K	5	9.9%
BELGIUM	$50.0K	1	4.3%
RUSSIA

Who Are the Top Buyers of Irbesartan from Micro Labs Limited?

Buyer	Country	Value	Orders
ARROW PHARMACEUTICALS PVT LTD	AUSTRALIA	$422.6K	13
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$330.8K	10
BROWN AND BURK LIMITED	UNITED KINGDOM	$100.0K	2
MSK PHARMALOGISTIC GMBH	GERMANY	$65.3K	4
ARROW PHARMACEUTICALS PRIVATE LIMITED	AUSTRALIA	$61.7K	4
ARROW PHARMACEUTICALS PVT LTD ,-	AUSTRALIA	$54.3K	2
MSK PHARMALOGISTIC GMBH.	GERMANY	$50.0K	1
MICRO LABS GMBH ,	BELGIUM	$50.0K	1
ARROW PHARMACEUTICALS PVT LTD,	AUSTRALIA	$26.1K	3
ALYONA CHORICH	RUSSIA	$0	3

Micro Labs Limited supplies Irbesartan to 11 buyers globally. The largest buyer is ARROW PHARMACEUTICALS PVT LTD (AUSTRALIA), followed by BROWN AND BURK UK LIMITED (UNITED KINGDOM) and BROWN AND BURK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Irbesartan Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
IRBESARTAN FILM-COATED TABLETS 150 MG (B	$142.3K	5
IRBESARTAN 300mg FILM-COATED TABLETS ( (	$100.0K	2
PHARMA:AVSARTAN 300 (IRBESARTAN 300MG FI	$91.6K	2
PHARMA:AVSARTAN 300(IRBESARTAN 300MG FIL	$87.4K	2
IRBESARTAN FILM-COATED TABLETS 150 MG B	$70.8K	2
PHARMA:AVSARTAN 150(IRBESARTAN 150MG FIL	$63.7K	2
IRBESARTAN 75MG FILM-COATED TABLETS BP	$50.0K	1
IRBESARTAN 300 MG FILM-COATED TABLETS IH IN BB LIVERY INV.QTY.34440 PACK 4X 7S	$50.0K	1
AVSARTAN IRBESARTAN 150MG IRBESARTAN 150MG FILM COATED TABLETS 3X10sX80880 -TAX DOCUMENT NO: 706204846 DT: 14.09.23	$50.0K	1
AVSARTAN 300 IRBESARTAN 300 MG FILM COATED TABLETS BP PACK 3X10S DOCUMENT QTY96080 TAX DOCUMENT NO.706204911	$50.0K	1

Micro Labs Limited exports 32 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN FILM-COATED TABLETS 150 MG (B with 5 shipments worth $142.3K.

How Does Micro Labs Limited Compare to Nearest Irbesartan Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	INTAS PHARMACEUTICALS LIMITED	$1.8M	156	5	$11.5K
11	JUBILANT GENERICS LIMITED	$1.3M	84	7	$15.1K
12	MICRO LABS LIMITED ★	$1.3M	41	6	$30.8K
13	AUROBINDO PHARMA LIMITED	$1.2M	109	3	$11.2K
14	MEPRO PHARMACEUTICALS PRIVATE LIMITED	$1.0M	71	1	$14.8K

Micro Labs Limited ranks #12 among 123 Indian Irbesartan exporters. Average shipment value of $30.8K compared to the market average of $473.0K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and JUBILANT GENERICS LIMITED.

Which Indian Ports Ship Irbesartan Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	284	10.6%
SAHAR AIR	197	7.4%
SAHAR AIR CARGO ACC (INBOM4)	170	6.4%
JNPT/ NHAVA SHEVA SEA	147	5.5%
DELHI AIR	135	5.1%
DELHI AIR CARGO ACC (INDEL4)	133	5.0%
JNPT	129	4.8%
MUNDRA SEA (INMUN1)	108	4.0%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Irbesartan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 47 individual customs records matching Micro Labs Limited exporting Irbesartan, covering 32 formulations to 6 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 68+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Irbesartan

Irbesartan

Micro Labs Limited — Irbesartan Exporter Profile

Micro Labs Limited — Irbesartan Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Irbesartan?

Who Are the Top Buyers of Irbesartan from Micro Labs Limited?

What Is India's Total Irbesartan Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Irbesartan Exports?

How Does Micro Labs Limited Compare to Other Indian Irbesartan Exporters?

What Irbesartan Formulations Does Micro Labs Limited Export?

Regulatory Requirements: Exporting Irbesartan to Key Markets

Australia — TGA

United Kingdom — MHRA

Germany — BfArM/EMA

How Does Micro Labs Limited Compare to Nearest Irbesartan Exporters?

Which Indian Ports Ship Irbesartan Exports?

Geopolitical & Trade Policy Impact on Micro Labs Limited's Irbesartan Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Irbesartan Export Data from Micro Labs Limited

Irbesartan Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source